A patient receiving cisplatin, vinblastine, and bleomycin for a testicular neoplasm develops renal impairment. This is effect of which drug(s)?
## Core Concept
The question tests the understanding of the side effects of chemotherapeutic agents, specifically nephrotoxicity. Cisplatin, vinblastine, and bleomycin are used in the treatment of testicular cancer. Nephrotoxicity is a well-known side effect of certain chemotherapeutic agents.
## Why the Correct Answer is Right
Cisplatin is a platinum-based chemotherapeutic agent known for its effectiveness against various types of cancers, including testicular cancer. One of its major side effects is nephrotoxicity, which can lead to renal impairment. This occurs through damage to the renal tubules and vasculature, leading to a decrease in renal function. The mechanism involves the formation of platinum-DNA adducts in renal cells, inducing apoptosis and necrosis. Therefore, when a patient develops renal impairment while receiving cisplatin, vinblastine, and bleomycin, cisplatin is the most likely culprit.
## Why Each Wrong Option is Incorrect
- **Option A:** Vinblastine is a vinca alkaloid that primarily causes myelosuppression and neurotoxicity as side effects, not nephrotoxicity.
- **Option B:** Bleomycin is known for its pulmonary toxicity, which can be severe, leading to pneumonitis and fibrosis. While it has various side effects, nephrotoxicity is not commonly associated with bleomycin.
## Clinical Pearl / High-Yield Fact
A key point to remember is that cisplatin-induced nephrotoxicity can be dose-limiting. Measures to mitigate this include adequate hydration, use of nephroprotective agents like amifostine, and dose adjustment based on renal function. Monitoring renal function is crucial in patients receiving cisplatin.
## Correct Answer Line
**Correct Answer: C. cisplatin**